Showing results (261-270 of 438) with videos related to

Sort By:
Pageof 44
Journal of Thrombosis and Thrombolysis|May 10, 2006
Low-molecular-weight heparin compared with unfractionated heparin for patients with non-ST-segment elevation acute coronary syndromes treated with glycoprotein IIb/IIIa inhibitors: results from the CRUSADE initiativeKanwar P Singh, Matthew T Roe, Eric D Peterson, et al.
The American Journal of Medicine|May 4, 2005
Pulmonary artery catheterization in acute coronary syndromes: insights from the GUSTO IIb and GUSTO III trialsMauricio G Cohen, Robert V Kelly, David F Kong, et al.
The American Journal of Medicine|November 28, 2013
NSAID use and association with cardiovascular outcomes in outpatients with stable atherothrombotic diseasePayal Kohli, Ph Gabriel Steg, Christopher P Cannon, et al.
American Heart Journal|October 12, 2010
Hormone replacement therapy among postmenopausal women presenting with acute myocardial infarction: insights from the GUSTO-III trialAndrea H Tackett, Alison L Bailey, Joanne Micale Foody, et al.
American Heart Journal|November 26, 2013
Use of ranolazine in patients with incomplete revascularization after percutaneous coronary intervention: design and rationale of the Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (RIVER-PCI) trialGiora Weisz, Ramin Farzaneh-Far, Ori Ben-Yehuda, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 21, 2005
Renal function, concomitant medication use and outcomes following acute coronary syndromesDonal N Reddan, Lynda Szczech, Manjushri V Bhapkar, et al.
Annals of Internal Medicine|November 23, 2006
Insurance coverage and care of patients with non-ST-segment elevation acute coronary syndromesJames E Calvin, Matthew T Roe, Anita Y Chen, et al.
American Heart Journal|July 5, 2021
Epicardial delivery of XC001 gene therapy for refractory angina coronary treatment (The EXACT Trial): Rationale, design, and clinical considerationsThomas J Povsic, Timothy D Henry, E Magnus Ohman, et al.
European Heart Journal|November 13, 2012
Resistant hypertension: a frequent and ominous finding among hypertensive patients with atherothrombosisDharam J Kumbhani, P Gabriel Steg, Christopher P Cannon, et al.
JAMA|October 4, 2012
β-Blocker use and clinical outcomes in stable outpatients with and without coronary artery diseaseSripal Bangalore, Gabriel Steg, Prakash Deedwania, et al.
Pageof 44